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Abstract: Total antioxidant capacity assays are recognized as instrumental to establish 
antioxidant  status  of  biological  samples,  however  the  varying  experimental  conditions 
result in conclusions that may not be transposable to other settings. After selection of the 
complexing agent, reagent addition order, buffer type and concentration, copper reducing 
assays were adapted to a high-throughput scheme and validated using model biological 
antioxidant  compounds  of  ascorbic  acid,  Trolox  (a  soluble  analogue  of  vitamin  E),  
uric acid and glutathione. A critical comparison was made based on real samples including 
NIST-909c human serum certified sample, and five study samples. The validated method 
provided linear range up to 100 µM Trolox, (limit of detection 2.3 µM; limit of quantification  
7.7 µM) with recovery results above 85% and precision <5%. The validated developed method 
with an increased sensitivity is a sound choice for assessment of TAC in serum samples. 
Keywords:  total  antioxidant  capacity;  cupric  ion  reducing  antioxidant  capacity;  serum 
samples; high-throughput microplate assay 
 
1. Introduction 
Antioxidants serve as a protection for the body against the harmful effects of free radical damage. 
Generally,  the  measurement  of  total  antioxidant  capacity  (TAC)  indicates  the  oxidant-buffering 
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potential of a tissue or biofluid. However, the use of serum TAC as a biomarker of oxidative damage is 
frequently criticized [1,2]: regarding the non-concordant results between in vitro and in vivo assays [3]; 
the dependence of results obtained on the chemistry of TAC assay applied [4]; as oxidation probes, 
targeted  molecules  and  measurement  conditions  differ  across  the  assays  used  for  plasma  [5,6]. 
Practical methodological aspects (pH, monitoring wavelength, assay time) [7] also play an important 
role in the interpretation of the results of TAC assays. 
One  group  of  antioxidant  capacity  assays  is  based  on  the  electron  transfer  (ET)  mechanisms.  
The most widely used ones resort to Vis-spectrophotometry for monitoring the bleaching of colored 
radical compounds. Ferric reducing antioxidant power (FRAP) [8] and cupric ion reducing antioxidant 
capacity (CUPRAC) [9] are similar from a theoretical point of view, as both are based on the reduction 
of metal complexes. 
In ET based methods, the reactivity is conditioned by the de-protonation and the ionization potential 
of functional groups. Therefore, ET reactions are pH dependent. Generally, ionization potential values 
decrease with increasing pH, which causes an increase in electron-donating capacity concomitant of 
de-protonation [10]. Hence, pH values have a major impact on the reducing capacity of antioxidants. 
At acidic conditions, the reducing capacity may be restrained or slowed down due to protonation on 
antioxidant compounds, whereas, in basic conditions, the dissociation of phenolic compounds with 
proton release will increase reducing capacity [11]. Regarding assays based on reduction of metal or 
on prevention of metal oxidation, redox active complexes of iron [8] and copper [9] are the most 
frequent choices as oxidant probes.  
For instance, the Ferric reducing antioxidant power (FRAP) assay is based on the reduction of the 
Fe(III)  complex  of  2,4,6-tripyridyl-s-triazin  (TPTZ)  by  antioxidants  and  the  intense  color  change 
induced by the appearance of the Fe(II)-TPTZ chelate is monitored at 593 nm. This assay has the 
advantage of using a spectrophotometric measurement at a wavelength far from the UV range where 
most samples (food, beverage or those with biological origin) have an intrinsic absorbance.  
The cupric reducing antioxidant capacity assays are based on the reduction of a Cu(II) complex the 
presence of antioxidants, in this case the color change is related to the reduced form of the complex 
which can be monitored at a visible wavelength. The advantages in using the cupric assay over the 
FRAP  one  include  the  working  pH,  which  is  closer  to  the  physiological  conditions  (pH  7.0  in 
CUPRAC vs. the pH ~3 necessary in FRAP). In general the copper based assays target the thiol group 
containing antioxidant species. The chromogenic oxidizing reagent used for the assay is a copper(II) 
cation chelate acting as an outer-sphere electron-transfer agent [12], and the chromophore, formed by 
reduction of this reagent with antioxidants, is the chelate-copper(I) cation. Due to the lower redox 
potential of the reagent complex in comparison with the FRAP assay, oxidizable substrates such as 
reducing sugars and citric acid (not targeted in antioxidant assays) are not oxidized by the copper 
complexes  [13].  Moreover,  the  low  redox  potential  enhances  redox  cycling  [14,15],  thus,  copper 
reduction can be used as a sensitive indicator of potential pro-oxidant activity of antioxidants [16,17]. 
Nevertheless, all copper reduction based assays applied to complex mixture of antioxidants have 
shown discrepant results related to the appropriate selection of reaction time [10]. This drawback can 
be handled in different ways. One way is stopping the reaction at a predefined reaction time, avoiding 
the need to wait until completeness of the reactions, which can be time consuming (>1 h) for slow 
acting  antioxidants,  or  even  impossible  to  achieve  if  recirculation  (redox  cycling)  phenomena  is Int. J. Mol. Sci. 2014, 15  11389 
 
considered. Therefore, Apak and his co-workers [9] opted to use a fixed reaction time (30 min) and 
Campos et al. [18] have chosen to stop the reaction by addition of a strong complexing agent (EDTA) 
after 3 min. Other possibility is to try to find a model compound (calibrator) with a kinetic behavior 
similar to that of the antioxidant pool present in samples [19,20]. This kinetic matching approach is 
based on the comparison of the oxidation behavior of standard compounds and was validated through 
the analysis of real complex sample matrices (red wine and samples of biological origin). 
The monitoring wavelength used in these assays can also present some disadvantages when sample 
background absorption is not negligible. In spectrophotometric assays sample background absorption 
is usually reduced by sample dilution, as in the case of red wine samples where extensive dilutions  
are necessary [21]. In the case of considerable intrinsic absorbance of an antioxidant compound itself  
(like  bilirubin)  the  contribution  of  this  compound  to  the  true  total  antioxidant  capacity  can  be 
overestimated [22]. Dilution is also chosen as a strategy to reduce interference effects [23], as other 
complexing  agents and metal ions present  in the sample  can  hinder the real antioxidant capacity. 
Extensive dilution of the samples can bring another disadvantage to the assessment of total antioxidant 
capacity, as samples might contain powerful antioxidant species that even at very low concentration 
can contribute significantly to the total capacity of the sample, and the contributing effect of these 
compounds can be “lost in dilution”.  
Therefore our present work is focused on (i) developing of a high-throughput microplate assay with 
increased  sensitivity  to  facilitate  the  assessment  of  antioxidant  capacity  at  low  antioxidant 
concentrations; (ii) evaluating the possibility of monitoring the presence of synergistic or autoxidative 
effects in the case of various antioxidant species present in samples of biological origin. 
2. Results and Discussion 
2.1. Complexing Agent Selection 
The  absorbance  spectrum  in  the  visible  region  (400–700  nm)  was  traced  for  the  three  copper 
complexes in the presence of 50 µM ascorbic acid against the corresponding blank solution containing 
only the chelating agent, copper, and the buffer solutions (Figure 1A). The longest wavelength for 
maximum absorbance was found for the BCA complex (558 nm), however the highest absorption was 
verified for the BCS at 485 nm (Figure 1B).  
Phenanthroline  derivate  reagents  (2,9-dimethyl-1,10-phenanthroline,  NC,  and  2,9-dimethyl-4,7-
diphenyl-1,10-phenantrolinedisulfonic acid, BCS) are diamine chelators which form 2:1 complexes 
with Cu(II) at pH 7.0 (see structural formula within supplementary information Figure S1A,B). In the 
presence of a reducing agent, the strong complex stabilizes the copper in its reduced form of Cu(I) in a 
tetrahedral binding geometry [24], while the induced conformational changes of the complex result in 
the appearance of a strong absorption band in the 450 to 550 nm wavelength range. As the molecular 
mass of the chelating agent increases the absorbance band intensity also increases, as can be confirmed 
on Figure 1B for NC and for BCS. 
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Figure 1. Absorption spectra for Cu(I) complexes and corresponding blank solutions (A); 
net absorption spectra (B); NC blank dashed blue line; NC in presence of ascorbic acid 
dashed red line; BCS blank solid green line; BCS in presence of ascorbic acid solid purple 
line; BCA blank dotted blue line; BCS in presence of ascorbic acid dotted orange line 
(reaction conditions given in Table S1 in presence of 50 µM ascorbic acid). 
 
Two molecules of bicinchoninic acid (Figure S1C) (2-(4-carboxyquinolin-2-yl)quinoline-4-carboxylic 
acid, BCA) will also chelate with copper ions and form a purple-colored product that strongly absorbs 
light at a wavelengths of 354 and 562 nm [25]. This reaction of BCA, whose mechanism is not fully 
understood yet, is widely used to assess protein concentration (Smith assay) [26]. 
All of the three complexes has high formational constants (logβNC = 19.5 [27]; logβBCS = 19.8 [28] 
and logβBCA = 14.7 [28]) showing high affinity towards Cu ions, assuring that the antioxidant assay 
will only evidence the reduction of the Cu complexes, and not Cu
2+ in its free form. The formation of Int. J. Mol. Sci. 2014, 15  11391 
 
other  metal  complexes  in  the  case  of  the  BCS  and  NC  assays  could  be  ignored  since  excess 
concentration of the Cu(II) is used in the reaction mixture. The concentrations of Cu
2+ (in the form of 
Cu aqua ions) present in the reaction mixture not complexed with NC or BCS is set at 2.5 mM. In the 
BCA assay, however, the concentration of Cu cannot be maintained in excess, since precipitation of 
the complex occurs [29]. To guarantee a complete complexation, without precipitation, the BCA must 
be added in stoichiometric ratio or in excess. Therefore, the potential complexation of other metal ions 
that might be present in the sample (for example Fe) cannot be ignored, and this situation limits the 
applicability of BCA. This effect was not noticed in the case of the other two complexants. 
2.2. Reagents Addition Order 
In a first approach the time sequence for addition of the reaction components was tested. This study 
was carried out using BCS as a copper chelating reagent in the presence of Trolox and ascorbic acid as 
antioxidants, the other reaction conditions were as detailed in Table S1. Less than 2  min elapsed 
between the additions of each reaction component. The different addition orders tested were (a) Cu
2+, BCS, 
Buffer, AOX; (b) Buffer, Cu
2+, BCS; AOX; (c) AOX, Buffer, Cu
2+, BCS; (d) AOX, Buffer, BCS, Cu
2+.  
The step of buffer addition assured that the complexation and the reduction of Cu
2+ occurred at the 
controlled pH of 7.0. The results obtained are represented in the form of calibration curves (0 to 100 µM) 
for ascorbic acid (Figure 2A) and for Trolox (Figure 2B). 
Figure  2.  Response  curves  for  ascorbic  acid  (A)  and  Trolox  (B)  antioxidants  using 
different reagent addition orders, (a) (○) Cu
2+, BCS, Buffer, AOX; (b) (□) Buffer, Cu
2+, 
BCS; AOX; (c) (●) AOX, Buffer, Cu
2+, BCS; (d) (Δ) AOX, Buffer, BCS, Cu
2+. 
 
One important detail concerning the analytical approach under these conditions is related to the 
order of addition of the reactants. Addition order effects can be significant, as can be concluded from 
Figure 2. The markedly different response of the addition order c (AOX, Buffer, Cu
2+, BCS), can be 
traced back to the reduction of the free (non complexed) Cu
2+ ions by the antioxidants before the 
complexation with BCS can take place. The different reduction potentials of 0.066 V for ascorbic acid 
vs. 0.192 V for Trolox in relation to the reduction potentials of the copper (ECu(II/I) = 0.17 V) and the 
copper-BCS complex (ECu(II/I)-BCS = 0.844 V) [30], is reflected in the different behavior find for the two Int. J. Mol. Sci. 2014, 15  11392 
 
antioxidant. The addition order c should be treated differently as it can lead to discrepancies in the results 
or to “apparent” interaction effects when various antioxidants are present in the sample solutions. Some 
of the literature data also indicate the occurrence of this phenomenon: in the presence of ascorbic acid in 
synthetic mixtures the found TE values were below the expected ones [31] and, in more recent articles, 
where this pre-reduction effect is exploited for the assessment of pro-oxidant behavior of ascorbic  
acid [16,17]. 
2.3. Trolox Equivalent Value 
The  relative  response  of  the  different  antioxidants  tested  was  established  based  on  the  Trolox 
equivalent values (TE) calculated according to Equation (1) in the experimental section. The obtained 
values are summarized in Table 1, and calibration curve parameters are exemplified in Table S2 in 
supplementary information. 
Table 1. Trolox equivalent (TE) values obtained using different copper complexing reagents.  
TE  Ascorbic Acid  Trolox  Uric Acid  Glutathione 
TE(BCS)  1.15 ± 0.02  1.00 ± 0.01  1.90 ± 0.02  0.62 ± 0.02 
TE(NC)  0.90 ± 0.03  1.00 ± 0.01  1.96 ± 0.02  0.54 ± 0.01 
TE(BCA)  1.03 ± 0.03  1.00 ± 0.04  2.46 ± 0.09  0.57 ± 0.02 
Results  correspond  to  calibration  curves  performed  in  three  working  days  for  each  complexing  agents  
(5 standards in 0–100 µM antioxidant solutions each assessed in quadruplicate). 
Confirming the additivity of the response given by the different antioxidant compounds present 
simultaneously in the samples is fundamental for a Total antioxidant capacity assay, as it will assure 
that the contribution of all the studied antioxidant compounds can be accounted for. Analytically, 
additivity is established if the sum of molar absortivities times the concentration of the antioxidants (TECalc) 
equals to the experimentally determined absorbance value (Equation (2) in the experimental section). 
This study is recognized as essential for the development of Total antioxidant capacity assays [9,31,32], 
however in the case of BCS complex a detailed study is missing from the literature [18,22]. In the 
present work this additivity was confirmed at two levels, (i) in binary mixtures of two antioxidants in 
sample solutions and (ii) in the simultaneous presence of the three biologically active antioxidants. 
Covariance data is presented for the study of the binary mixtures of the antioxidants (Table S3), 
with the 95% confidence interval computed for each equation parameter; while in Table 2 the results 
obtained when three antioxidant compounds were simultaneously present can be found.  
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Table  2.  Calculated  (TE  expected)  and  determined  (TE  found)  values  for  solutions 
containing three antioxidant compounds simultaneously using the BCS complex. 
[AA] µM  [AU] µM  [GSH] µM  TE Expected  TE Found Average ± SD  RD% 
a 
10  10  10  0.037  0.038 ± 0.000  3.0 
10  10  50  0.065  0.066 ± 0.000  1.7 
10  50  10  0.111  0.112 ± 0.001  0.5 
10  50  50  0.139  0.142 ± 0.001  1.8 
50  50  10  0.157  0.158 ± 0.004  0.9 
50  50  50  0.185  0.188 ± 0.001  1.9 
50  10  10  0.082  0.085 ± 0.003  2.7 
50  10  50  0.110  0.114 ± 0.001  2.9 
a RD%, Relative deviations (%) of the means: (TE found − TE expected) × 100/TE expected. 
2.4. TE of Biological Antioxidants in Mixtures 
The three complexing agents studied gave similar values for Trolox equivalent (Table 1), indicating 
the same order of “antioxidant power” for the studied compounds: uric acid > ascorbic acid ≈ Trolox > 
glutathione. Relative TE values based on the comparison to Trolox as a reference compound indicate 
4,  2,  and  1  electron  transfer  processes  for  uric  acid,  ascorbic  acid  and  glutathione,  respectively. 
Literature data in most cases indicate similar values; however the relative response of uric acid is not 
always coincident with the 4 electron transfer mechanism. This variation will reflect on the results  
for  antioxidant  capacity  assays,  and  can  justify  the  highly  variable  results  obtained  in  biological 
samples [20,33,34] where uric acid constitutes an important antioxidant reserve. Based on the previous 
considerations the most sensitive reagent (BCS) was selected for the further studies. 
No evident interaction of the antioxidants can be detected as the intercept and the slope values  
of the adjusted models were not statistically different from 0 and 1, respectively (Table S3). It is 
important to stress that in these assays care was taken to assure the shortest time possible (below  
5 min) between the preparation of the antioxidant mixtures and the addition to the microplate. The 
same conclusions were found when the three antioxidant compounds were simultaneously present in 
different concentrations (Table 2), as relative deviations between the expected and found TE values 
were ≤3%. These results indicate the applicability of the method to total antioxidant capacity assays. 
2.5. Buffer Solutions 
The operating pH of Cu reducing TAC assays provides an advantage when biological samples are 
concerned compared to other ET assays. However the nature of the buffer solution can be variable, 
with reported utilization of PBS [18], Tris-glycine urea [34] and ammonium acetate [35]. In the present 
study, the response of the different antioxidants in these buffer solutions was evaluated and compared 
(Table 3). Figure 3 shows the different time course (kinetic response) of uric acid and Trolox in the 
three buffering systems. 
In the case of biological samples the working buffer solution employed have important effects  
on the stability  of the protein  fraction and  therefore on the obtained results.  As the experimental 
conditions (namely the chosen chelating agent and the applied assay time) are very different in the Int. J. Mol. Sci. 2014, 15  11394 
 
literature-described applications, in the present work response of the different model compounds in the 
three buffer solution using the BCS reagent was evaluated during 1 h. The results indicate similar 
calibration curves for ascorbic acid, Trolox and glutathione, but uric acid shows a different behavior 
(Table 3). 
Table  3.  Comparison  of  Trolox  equivalent  values  (TE)  obtained  for  the  antioxidant 
compounds, in different buffer solutions using BCS as a complexing agent. 
Buffer  Ascorbic Acid  Trolox  Uric Acid  Glutathione 
Ammonium acetate, pH 7.0  1.148 ±  0.024  1.000 ± 0.008  1.899 ±  0.013  0.624 ±  0.018 
Tris-glycine urea, pH 7.0  0.813 ±  0.040  1.000 ± 0.050  0.983 ±  0.049  0.552 ±  0.028 
PBS, pH 7.4  0.991 ±  0.044  1.000 ± 0.050  0.766 ±  0.038  0.668 ±  0.033 
Results correspond to calibration curves performed using the three buffer solutions (5 standard antioxidant 
solutions in 0–100 µM concentrations range each assessed in quadruplicate). 
Literature data is also divergent on the TE value of uric acid, Apak et al. initially reports TE(NC) = 0.96 
and 1.54, later Celic et al. [34] reported TE(NC) = 1.050; Campos et al. [18] refers TE(BCS) = 1.08 and in 
an earlier work of our group Ribeiro et al. [20] set the TE(NC) at 1.74. The nature of the buffer solution 
seems  to  influence  greatly  the  TE  values.  The  oxidation  process  of  uric  acid  can  follow  various 
pathways;  Robinson  et  al.  [36]  postulate  one  main  route  of  two  electron  transfer  leading  to  the 
formation of allantonin, and a four electron transfer pathway leading to the formation of triuret. It is 
also proposed that triuret in the presence of oxidants will originate an amino carbonyl radical. Under 
the experimental conditions oxidants remain in excess in the reaction mixture at the time of detection. 
Therefore, this radical formation process (through the auto-oxidation of urate) is probably the cause for 
the kinetic curve of uric acid (Figure 3B) not reaching a constant value like in the other buffer solution.  
Figure 3. The influence of buffer solution composition on the absorbance readout for (A) 
Trolox and (B) uric acid at 40 µM. Dashed line is used for the ammonium acetate buffer, 
dotted line for PBS and solid line for the Tris-urea buffer. Other conditions are as detailed 
in Table S1. 
 
The Tris-glycine buffer with 8 M urea [37] contains also 4 mM citrate, therefore chelation of copper 
by the buffer components can also occur under the used experimental conditions [38]. Celic et al. [34] Int. J. Mol. Sci. 2014, 15  11395 
 
refers that the use of this buffer is necessary to avoid the precipitation of the protein fraction of the 
sample, and add that the presence of 8 M urea partly denaturates proteins and significantly lowers the 
reduction potential of disulfide/thiol couples in peptides facilitating thiol oxidizability.  
It is currently estimated that albumin contributes to 60%–70% of the antioxidant capacity of serum, 
either  directly  via  free  reducing  thiol  groups,  or  indirectly  by  protecting  the  antioxidants  from  
oxidation  [39].  In  serum  samples,  quantifying  the  contribution  of  the  protein  fraction  to  the  total 
antioxidant capacity can be a troublesome process. Frequently, the protein fraction is separated by 
precipitation,  applying  isoelectric  precipitation  with  perchloric  acid  or  trichloroacetic  acid,  or  by 
salting out with addition of ammonium sulfate. The total antioxidant capacity can then be assessed on 
the protein free fraction [8,40]. An analytical method with ability to assess the TAC of serum samples 
without separation of the protein fraction has advantages providing (i) a simpler sample preparation 
procedure; (ii) the possibility of assessing protecting effects of protein fraction. The Tris-glycine buffer 
with 8 M urea has been used for TAC assay successfully [34], and showed linear response when 
different dilutions of the sample were analyzed. PBS and 1 M ammonium acetate buffers were only 
used in protein free samples. The ammonium acetate concentration applied in this latter buffer induces 
steric changes in the protein structure (salting out effects) therefore precipitation may be observed. 
2.6. Sample Analysis and Validation 
Analytical  features  of  the  developed  method  were  calculated  based  on  the  calibration  curves 
established at three working days (Table S3). Back calculated concentrations for linearity assessment 
are listed in Table 4. 
Table  4.  Back  calculated  concentrations  of  standards  for  ascorbic  acid,  uric  acid, 
glutathione and Trolox. 
Nominal Conc. (µM)  Ascorbic Acid (µM)  Uric Acid (µM)  Glutathione (µM)  Trolox (µM) 
10  10.0 ± 0.7  10.0 ± 0.6  9.9 ± 0.5  10.5 ± 0.6 
20  20.3 ± 0.9  20.0 ± 0.7  21.8 ± 0.7  20.2 ± 0.7 
40  39.8 ± 2.0  39.6 ± 1.7  42.0 ± 0.9  40.6 ± 0.7 
60  59.3 ± 2.6  60.3 ± 1.9  61.0 ± 1.3  61.0 ± 1.2 
100  99.9 ± 2.8  100 ± 1.5  97.9 ± 1.9  100.9 ± 1.1 
n = 12, corresponds to 3 working days and assays in quadruplicate. 
The limit of detection (2.3 µM), was estimated from the standard error of the Trolox calibration 
curve [41], while the limit of quantification corresponds to 7.8 µM. The application range extends  
to  100  µM  Trolox.  Precision  values  obtained  from  calibration  curves  in  3  working  days  at  five 
concentration levels and in quadruplicate assays for the four antioxidants studied are summarized in 
Table S4. Sample stability results assessed under different storage conditions are presented in Table S5. 
Recovery  assay  results  with  two  level  addition  of  uric  acid  in  the  different  samples  (n  =  5)  are 
summarized in Table 5. 
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Table 5. Recovery assay results for two level addition of uric acid in five serum samples. 
Sample 
Absorbance  TEAC (µM) 
Recovery%  Added Uric Acid Concentration  Trolox Equivalent (µM) 
0 µM  25 µM  0 µM  44.1 µM 
S1  0.260 ± 0.002  0.524 ± 0.006  25.7 ± 0.2  66.7 ± 0.8  93.0 
S2  0.271 ± 0.004  0.518 ± 0.006  27.4 ± 0.4  66.1 ± 0.7  87.9 
S3  0.235 ± 0.005  0.493 ± 0.004  21.6 ± 0.4  62.2 ± 0.5  92.0 
S4  0.265 ± 0.003  0.511 ± 0.005  26.4 ± 0.3  65.1 ± 0.6  87.7 
S5  0.275 ± 0.004  0.520 ± 0.005  27.9 ± 0.4  66.5 ± 0.7  87.6 
n = 8, corresponds to duplicate determinations in quadruplicate assays. 
A serum sample of Standard Reference Material 909c of the National Institute of Standards and 
Technology (USA), containing 0.278 ± 0.006 mM of uric acid, was analyzed using the three buffer 
solutions to confirm their influence on results. Sample dilutions in the range of 50 to 200 times were 
prepared.  However,  samples  diluted  less  than  100  times  showed  precipitation,  resulting  that  the 
analytical signal was proportional to the turbidity of the solutions. Therefore, total antioxidant capacity 
of the sample (at 200 times dilution) was assessed based on the Trolox calibration curve established 
using  the  three  buffer  solutions,  and  the  resulting  TAC  values  for  PBS,  Tris-glycine  urea,  and 
ammonium acetate were 4.1 ± 0.5, 7.8 ± 0.6, and 1.75 ± 0.04 mM, (n = 3) respectively. Limitations 
imposed by the quantification limit did not allow higher than 200 times dilutions, and for sample  
inter-comparability in the validation procedure the sample dilution was fixed at 200 times.  
Stability of the standard solutions was not evaluated in this study as it is a consensus practice to use 
freshly prepared working solutions of the antioxidants. Sample stability results indicate that the matrix 
antioxidant compounds are stable during storage at −18 °C for at least 2 weeks. Four freeze-thaw 
cycles at ambient temperature during 1 h were also well supported. However, >10% decrease was 
observed for sample standing 24 h at room temperature (Table S5). 
Recovery data indicates a good agreement (Table 5) as the recovery was >85% for the uric acid 
addition. Uric acid was used in this study since major contribution to the TAC of the samples is 
expected from this analyte.  
Regarding precision the % CV values in the study samples (1%–2.1%) were not different from the 
ones obtained for the standard solutions (1%–5.5%), indicating that the diluted sample matrix did not 
influence the method overall precision. 
3. Experimental Section  
3.1. Materials 
All chemicals used were of analytical reagent grade and were purchased from Sigma Aldrich, MO, 
USA if not otherwise stated. Ultrapure water from Sartorius AriumPro system (resistivity > 18.2 MΩ·cm) 
was used in the preparation of all solutions. 
For the microplate-reader method, 10 mM copper solution was prepared by dissolving CuCl2·2H2O 
in  water.  Complexing  agent  solutions  in  water  were  prepared  from  neocuproine  hydrochloride 
monohydrate  (NC,  CAS:  303136-82-5,  Sigma  72090),  bathocuproinedisulfonic  acid  disodium  salt Int. J. Mol. Sci. 2014, 15  11397 
 
(BCS, CAS: 52698-84-7, Sigma B1125), and bicinchoninic acid disodium salt hydrate (BCA, CAS: 
979-88-4, Sigma D8284) by dissolution in water in concentrations of 7.5, 7.5 and 6 mM, respectively. 
Ammonium acetate buffer (1.0 M) pH 7.0 was prepared by dissolving 3.85 g of ammonium acetate in 
50.0 mL of water. In addition to the ammonium acetate buffer, phosphate and Tris-glycine-urea buffers 
were also prepared following the literature recommendations. For the phosphate buffer Dulbecco’s 
phosphate buffer saline (Sigma D1408) was used at 10 mM. The Tris-glycine-urea buffer contained 
0.086 M tris(hydroxymethyl)aminomethane, 0.09 M glycine, 4 mM  citrate and 8 M urea (Merck, 
Darmstadt, Germany) with the final pH adjusted to 7.0. 
The  stock  solutions  of  the  antioxidants  were  prepared  daily.  The  stock  solutions  of  2.00  mM 
ascorbic acid (AA, CAS: 50-81-7, Fluka 95210) and 1.00 mM of reduced glutathione (GSH, CAS:  
70-18-8,  Sigma  G6529)  were  prepared  by  dissolving  the  respective  solids  in  water.  Trolox  
(CAS: 53188-07-1, Fluka 56510) solution at 1.00 mM was prepared by dissolving 25.0 mg of the solid 
in 5 mL of ethanol followed by completing the volume to 100 mL with water. The stock solution of 
1.00 mM uric acid (UA, CAS: 69-93-2, Sigma U2625) was prepared by suspending the corresponding 
solid in 20 mL water, the pH of the resulting solution was raised by drop-wise addition of 0.1 M 
NaOH solution until complete dissolution of the solid (pH 11–12), followed by the elimination of the 
excess of base by addition of 0.1 M HCl solution until reaching pH 7.0. Afterwards the total volume of 
the solution was completed to 100 mL with water. Working standard solutions of antioxidants in the 
range of 10 to 100 µM were prepared by adequate dilution in water.  
3.2. Instrumentation 
Microplate reader was a BIOTEK, Synergy HT (Highland Park, VT, USA), with microplates of  
96 wells (Orange Scientific Cat # 4430100, Braine-l’Alleud, Belgium), a glass pH electrode (Crison, 
52-02, Barcelona, Spain) and potentiometer (Crison, pH meter GLP 22, Barcelona, Spain) were used, 
following the protocol detailed in Supplementary information (Table S1). Briefly, equal volumes (50 µL) 
of  the  complexing  agent,  copper  solution  and  buffer  solution  were  pipetted  in  this  order  and  in 
quadruplicate into a micro well plate, followed by the addition of 100 µL the antioxidant solution  
(e.g.,  single  standard,  binary  or  tertiary  mixtures  or  sample  solution).  Absorbance  change  was 
monitored during 1 h in 1 min intervals in the kinetic mode of the reader, for quantification purposes 
the absorbance values corresponding to the 1 h readings were used.  
3.3. Validation and Sample Analysis 
The  difficulty  in  validation  of  bioanalytical  methods  for  multianalyte  assays  or  for  assays  on 
parameters  involving  total  concentration  of  various  chemical  identities  is  widely  recognised  [42].  
Total  antioxidant  capacity  assays  fall  outside  the  scope  of  guidelines  published  for  validation  of 
bioanalytical methods [43,44]. In the present work these guideline protocols were followed to assess 
the selectivity, accuracy, precision, recovery and sample stability of the developed method. 
Selectivity  in  the  present  case  cannot  be  assessed  in  the  same  manner  as  chromatographic 
separations  as  multiple  analytes  contribute  to  the  total  antioxidant  capacity.  It  is,  thus,  important  
that the relative contribution of the different analytes is quantified. Therefore, analytical curves were 
established for the different analytes in study and their relative contribution was evaluated. Int. J. Mol. Sci. 2014, 15  11398 
 
The  relative  response  of  the  different  antioxidants  tested  was  established  based  on  the  Trolox 
equivalent  values  (TE).  These  values  were  calculated  from  the  slope  of  the  linear  response  curves 
(calibration curves) obtained for the antioxidants, therefore the value is the unity for Trolox (Equation (1)). 
        
           
             
  (1) 
Linearity was evaluated using calibration curves obtained in 3 working days, with freshly prepared 
stock  and  working  standard  solutions.  Precision  and  accuracy  were  evaluated  through  standard 
solutions and back calculated concentrations within the calibration range. Sample analysis precision 
was assessed from 2 replicate samples in quadruplicate assays (n = 8), after 200 times dilution. 
Quantitative evaluation of matrix/mutual interference effect due to interactions of AO compounds 
was based on the comparison of the TE values obtained from the absorbance values of the mixed 
standard  solutions  (2  or  3  component)  and  the  expected  TEAC  value  based  on  the  known 
concentrations of the antioxidants and their TE values (Equation (2)). The mixed standard solution 
preparation protocol is detailed within the supporting information (Table S6). 
 
(2) 
Lower  and  upper  limits  of  quantification  were  estimated  from  the  Trolox  calibration  curves 
established daily in three different working days [41]. 
Recovery assays were performed at two concentration levels using uric acid as model analyte. 
Absorbance values obtained before and after addition were compared to the ones expected after the 
addition of the known amount of the analyte, and taking into account the TE value of the uric acid.  
The evaluation of sample stability is a key topic in bioanalytical method validation [42]. To mimic 
the actual sample processing steps as recommended [43,45] aliquots of a sample were subjected to  
3 repeated freeze-thaw cycles, long term (2 weeks) storage at −18 °C and a short term (24 h) room 
temperature storage.  
A serum sample of Standard Reference Material 909c of the National Institute of Standards and 
Technology (USA), containing 0.278 ± 0.006 mM uric acid, was analysed. Sample dilutions in the 
range of 50 to 200 times were prepared. Five study serum samples (from healthy volunteers) were also 
used for validation purposes. 
4. Conclusions  
Total antioxidant capacity methods based on spectrophotometric detection are important for the 
analysis  of  biological  samples,  and  experimental  conditions  of  Cu  reducing  assays  are  clearly 
advantageous over other methods based on the same principle. However, some important conditions 
have to be met so that the results can be conclusive and intercomparable.  
  An additive response should be provided for the targeted group of antioxidants in the applied 
concentration range, because as long as the additivity is verified, the nature of the used Cu 
complexing agent does not seem to influence the results;  
  Additive response is provided as long as the oxidant complex is maintained in molar excess 
considering the electron transfer processes;  
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  Selection of the buffering system affects more the TE values that the complexing agent used, 
and this is related to the electron transfer mechanisms of the antioxidants; 
  The selection of buffer solution is also important to avoid measurement artefacts due to protein 
precipitation in biological samples. 
There is a need for further mechanistic investigations focused on antioxidant interactions in relation 
to health effects in humans. The copper reduction based spectrophotometric methods are sensitive 
markers  to detect changes of total antioxidant capacity, which  may  not  be  detectable through the 
measurement of single “specific” antioxidants. Therefore we believe that the copper reduction based 
total antioxidant capacity assays under strictly controlled experimental conditions is an important tool 
in assessing serum TAC. 
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